Alcon N 2.Linie (ALCE)
SIX
Closed
Aug 25, 2026
Day's Range
57.1252 wk Range
48.16Overview - ALCE - Alcon N 2.Linie
Key Statistics
Valuation
Enterprise Value
25.20B
P/E (Trailing)
‪54.40‬
Price / Book
‪1.59‬
EV / EBITDA
‪13.08‬
Profitability
Gross Margin
‪56.35%‬
Profit Margin
‪5.92%‬
Operating Margin
‪14.63%‬
Return on Assets
‪2.79%‬
Return on Equity
‪2.94%‬
Ownership
Shares Outstanding
487.70M
Float
481.82M
Price stats
Beta
‪0.69‬
50-Day Avg
‪55.66‬
200-Day Avg
‪54.44‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - ALCE - Alcon N 2.Linie
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on SIX.
- ALCESIXAlcon N 2.Linie+11.63%52-week change53.38P/E (Trailing)‪5.92%‬Profit Margin
- SRT3SIXSartorius AG Preference Shares+1.30%52-week change80.76P/E (Trailing)‪5.47%‬Profit Margin
- STMNSIXStraumann Holding AG-1.12%52-week change40.22P/E (Trailing)‪14.00%‬Profit Margin
- YPSNSIXYpsomed Holding AG+1.95%52-week change24.88P/E (Trailing)‪30.36%‬Profit Margin
- FIESIXFielmann Group AG-3.00%52-week change18.39P/E (Trailing)‪8.38%‬Profit Margin
- TECNSIXTecan Group AG+10.74%52-week change24.57P/E (Trailing)‪-13.36%‬Profit Margin
- AMSSIXams OSRAM AG+44.02%52-week change-13.66P/E (Trailing)‪-9.73%‬Profit Margin
Profile Summary - ALCE - Alcon N 2.Linie
About
Alcon N 2.Linie is a Swiss pharmaceutical and medical devices company specializing in eye care solutions. The company develops, manufactures, and markets a comprehensive portfolio of products designed to address various ophthalmological conditions and needs. Its offerings include prescription medications for eye…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
